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Abstract 
Due to their osteoconductive and inductive properties, a variety of calcium phosphate (CaP) 
scaffolds are commonly used in orthopaedics as graft material to heal bone defects. In this 
study, we have used two CaP scaffolds with different hydroxyapatite (HA) and β-tricalcium 
phosphate (β-TCP) ratios (MBCP®; 60/40 and MBCP+®; 20/80), to investigate their intrinsic 
capacity to favour human bone marrow stem cells (hBMSC) osteogenic differentiation 
capacity. We report that MBCP+® showed in in vitro culture model a higher rate of calcium ion 
release in comparison with MBCP®. In two defined co-culture systems, the hBMSC seeded 
onto MBCP+® presented an increased amount of VEGF secretion, resulting in an enhanced 
endothelial cell proliferation and capillary formation compared to hBMSC seeded onto 
MBCP®. When both ceramics combined with hBMSC were implanted in a nude mouse model, 
we observed a faster osteogenic differentiation and enhancement mature bone deposition 
sustained by the presence of a vast host vasculature within the MBCP+® ceramics. Bone 
formation was observed in samples highly positive to the activation of Calcium sensing 
receptor protein (CaSr) on the surface of seeded hBMSC that also shown higher BMP-2 protein 
expression. With these data we provide valuable insights in the possible mechanisms of 
ossification and angiogenesis by hBMSC that we believe to be primed by calcium ions released 
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Introduction 
Canonical tissue engineering approaches involve seeding of stem cells onto properly designed 
biomaterials to induce cellular differentiation through pre-defined pathways with tissue 
regeneration as the final target (Quarto, 2003; Oreffo & Triffitt, 1999). For bone repair, 
synthetic calcium phosphate (CaP) ceramic scaffolds have been used as graft substitutes 
because the chemical composition resembles the bone mineral phase (Espitalier et al., 2009; 
Komlev et al., 2010; LeGeros, 2008; Mastrogiacomo et al., 2006). Maximization of 
osteoconductive and osteoinductive properties of CaP scaffolds is one of the main objectives 
to better apply ceramics in bone tissue engineering (A M C Barradas, Yuan, van Blitterswijk, 
& Habibovic, 2011; G Daculsi, Laboux, Malard, & Weiss, 2003; Komlev et al., 2010). 
Parameters like chemical composition, micro and macro porosity are involved in 
osteoinductive properties, and macroporosity in osteogeneic capacity of MSC differentiation 
(niche concept) are optimized to achieve better clinical outcomes (A M C Barradas et al., 2012; 
Guy Daculsi, 2015; Guy Daculsi & Layrolle, 2004). Over the last few years, the role of CaP 
scaffolds has been changing from a structural passive function to one in which the intrinsic 
properties act as fundamental key in the whole orchestra of tissue regeneration (Daculsi et al., 
2013; Liu et al., 2004; Le Nihouannen et al., 2005; Place et al., 2009; Tampieri et al., 2011). 
When ceramics are used as vehicles to deliver human bone mesenchymal stromal cells 
(hBMSC) to trigger de novo bone formation, seeded cells and the host recipient 
microenvironment are crucial for the implant success. The complex process needed to 
formation of a new and organized host vasculature during bone repair is influenced by several 
events including interaction of different types of cells and the release of soluble factors, 
cytokines and matrix macromolecules (S Ghanaati et al., 2011; Novosel, Kleinhans, & Kluger, 
2011). Among these, vascular endothelial growth factor (VEGF) plays an important role in the 
cascade of events that guides the bone formation and maturation, i.e. by direct 
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intramembranous ossification or by endochondral ossification (Ferrara, Gerber, & LeCouter, 
2003; Kanczler & Oreffo, 2008; Novosel et al., 2011).  Likewise, the dissolution of ceramics 
main elements, e.g. calcium (Ca2+) and phosphate (PO43-), has an important role on 
osteogenesis in which diverse mechanisms are linked to cell sensibility to external Ca2+ 
variations. Calcium can enter the cell membranes through G-protein coupled receptors 
(GPCRs) (A M Hofer & Lefkimmiatis, 2007; Matsubara et al., 2008; Yao et al., 2014). Realize 
an in vivo regulation of BMP-2 expression and secretion in hBMSC seeded onto CaP ceramics, 
via modification of the extracellular Ca2+ concentration, could lead to clarify mechanisms that 
would re-direct strategies in bone tissue engineering. 
Herein we have; i) investigated how hBMSC seeded onto two different types of CaP ceramic 
scaffolds regulate proliferation and function of HUVEC cells in vitro; ii) studied how ions 
released from CaP scaffolds could prime the ossification process of hBMSCs; iii) analysed how 
CaP scaffolds could influence in vivo ossicle formation and maturation and at the same time 
the engraftment of host endothelial cells in the implanted scaffolds. 
 
Materials and Methods 
Calcium phosphate characterization  
Calcium phosphate ceramic scaffolds were provided by Biomatlante SA (Vigneux-de-
Bretagne, France) under EU GAMBA-Project from FP7 framework (NMP3-Sl-2010-245993). 
The macro and microstructure of the different ceramics was evaluated using Scanning electron 
microscope (SEM) (Leo 1450VP, Zeiss, Germany). Composition of ceramics (ratio of HA and 
β-TCP) was determined by X-ray diffraction (XRD) (Philips Analytical X ray BV 
diffractometer, Nederland) and Fourier transform infra-red spectroscopy (FTIR), (Nicolet 
Magnall, USA). Porosity was determined by Hg porosimetry (Micromeretics Autoport3), the 
SSA specific surface area using BET (ASAP 2010 Micromeritics), and mechanical testing by 
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TH HD plus Texture Analyseur made on calibrated samples (5mm in diameter and 8mm 
height).  The micro/macro-porous sizes of the different ceramics were analysed in 3D using X-
rays micro CT, using CT software for quantification.  
Calcium release profile was determined by immersing 10 mg of 0.5-1 mm ceramic particles in 
50 mL of simulated physiological saline solution (0.8% NaCl, 50 mM Hepes, pH 7.0) at 37 °C 
under constant agitation. Calcium content in the solutions at each time point for 240 minutes 
was monitored and quantified by a colorimetric assay kit (BioVision, CA, USA) according to 
the manufacture instructions.  
 
Cell isolation and culture 
1. Human Bone Marrow Stromal Cells 
Human BMSC were derived from iliac crest marrow aspirates of healthy donors after informed 
consent. Human samples were obtained from EU-PurStem Consortium, after approval by the 
Clinical Research Ethical Committee at University College Hospital, Galway, Ireland.  Briefly, 
cell-nucleated fraction of 20 mL bone marrow aspirate were suspended in Coon’s modified 
Ham’s F-12 medium (Biochrom) supplemented with 10% fetal calf serum (EuroClone), human 
recombinant fibroblast growth factor 2 (FGF-2) (1ng/mL) (Prepotech), 100 IU/mL penicillin 
and 100 mg/mL streptomycin, 2 mmol/L Lglutamine (EuroClone), and plated at a density of 
1x106 cells/cm2 (Muraglia, Martin, Cancedda, & Quarto, 1998a). Medium was changed twice 
a week. When culture dishes were nearly confluent (passage 0), BMSC were detached with 
trypsin-EDTA (Gibco) and 0.5 x 106 cells were re-plated in 100 mm dishes (passage 1). At the 
next sub-confluence, cells were detached and 2.5x106 BMSC seeded on the two different 
ceramics and implanted subcutaneously on the back of CD-1 nu/nu (Charles River – Calco, Lc, 
Italy) (Goshima, Goldberg, & Caplan, 1991). Three different BMSC primary cultures were 
tested with eight animals for each condition were implanted. 
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2. Human Umbilical Vein Endothelial Cells. 
Human Umbilical Vein Endothelial Cells (HUVEC) were cultured in M199 medium (Gibco) 
supplemented with 10% FCS, Endothelial Growth Factor (EGF) 2 ng/ml (Prepotech), Heparin 
10 g/ml, and Hydrocortisone 10 g/ml (Sigma). All cellular experiments were performed in 
a 5% CO2 humid atmosphere at 37
oC.  
 
HUVEC proliferation and differentiation assays  
hBMSCs were seeded on the ceramic scaffolds and cultured for 6 days. Afterwards, ceramics 
were extensively washed with PBS and placed in serum free medium (SF) for 2 days, 
demonstrated to be the optimal time to evaluate HUVEC response without cellular alterations.  
To co-culture BMSC with HUVEC, we used transwell system (Corning®). BMSCs were seeded 
onto ceramics at a cell density of 2.5x106 cells/scaffolds and placed in the transwell lower 
chambers, whereas HUVEC (5x103 cells) were seeded in the transwell inserts (polycarbonate 
membrane with pore size 0.4 μm) previously coated with gelatin (10 mg/ml for 10 minutes at 
room temperature) (Figure 1A). After 2 days, cells were fixed with paraformaldehyde (PFA) 
3.7% for 10 minutes, washed with PBS and stained with DAPI (10 mg/ml). Cells were counted 
in five ROIs for each condition. 
HUVEC capillarity capacity was assessed using a similar non-direct co-culture system. 
Calcium phosphate ceramics seeded with hBMSC were placed at the bottom of 24 multi-wells. 
Matrigel (BD, UK) was added to the well plate (500 μl/well) in order to totally cover the 
calcium phosphate ceramics. After gelation at 37oC in a humidified atmosphere with 5% CO2 
for 10 minutes, 7 x 104 cells were layered on the top of Matrigel in 100 μl of DMEM (Fig. 2a). 
Capillary tube formation was measured after 6 and 24 hours, by counting the internodes of the 
capillary network formed. Values were normalized by the counted number of internodes 
formed in presence of CaP without hBMSCs. Huvec capillary tube formation in absence of 
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ceramic scaffolds was also made. Representative figures of the experiments are shown in 
Supplementary Figure 2. 
 
VEGF quantification assay 
hBMSCs were seeded onto the ceramics and kept in culture (Ham’s F-12 complete medium) 
for 6 days. Thereafter, ceramics were washed extensively with PBS to remove FCS growth 
factors, and placed in 1 ml of serum free (SF) medium for 2 days. Conditioned media (CM) 
were collected and kept at -20°C until further analysis.  VEGF present in the media was 
quantified by means of enzyme-linked immunosorbent assay (ELISA) (R&D Systems, UK) 
according to manufacturer’s protocols. 
 
Histology 
Explanted samples were both decalcified and processed to obtain paraffin embedded, cryo-
sections and non-decalcified samples. In brief, decalcified samples were PFA-fixed, decalcified 
with Osteodec (Bio-Optica, Milano, Italy) and embedded in paraffin or in OCT (Thermo 
Scientific, USA) using standard histological procedure. 4 μm serial sections were cut and 
sections were stained with haematoxylin and eosin (H&E). Cryo-sectioned samples were used 
for immune-fluorescence detection of BMP-2. For resin embedding, explanted and fixed 
calcium phosphate ceramics were infiltrated with the light-curing resin Technovit 7200VLC 
(Kulzer, Wehrheim, Germany) for 21 days under vacuum with resin replaced every 7 days. 
Samples were polymerized by the EXAKT 520 polymerization system (EXAKT Wehrheim, 
Bio-Optica, Italy) with curing performed with 450 nm light at temperature bellow 40°C. 
Samples were cut using EXAKT 310 CP cutting unit (EXAKT Wehrheim, Bio-Optica, Italy). 
Obtained sections were approximately of 150 µm in thickness. Samples were then grinded to 
20–30 µm thickness using the EXAKT 400 CS micro grinding unit (EXAKT Wehrheim, Bio-
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Optica, Italy). Sections were stained with Stevenel’s/Van Gieson. For all processed ceramic 
samples, images were taken using Axiovert 200M microscope (Zeiss, Germany). 
 
Vascular and bone histomorphometric assays 
Calcium phosphate ceramics were fixed, decalcified and embedded in paraffin as described 
above. To visualize and quantify vascular structures in the calcium phosphate ceramics, 4 m 
sections were cut and stained with Mallory’s trichrome according to manufacturer’s 
instructions (Bio-Optica). Five non-consecutive sections for each sample were observed in 
transmitted light. Image J64 software was used to quantify the number of vessels for each ROI 
through the followed steps: (i) vessel perimeter was manually defined; (ii) vessels were 
counted; (iii) number of vessels for ROI were determined.  To quantify deposited bone, 4 m 
sections were stained with H&E and analysed in transmitted light. Five non-consecutive 
sections for sample were analysed using Image J64 software to calculate bone matrix 
deposition area as follows: bone and scaffold areas were delimitated and the ratio between both 
areas converted to percentage of bone per ROI.  
 
Immunohistochemistry 
Immunoperoxidase was performed to detect human Calcium Sensing Receptor protein (CaSr) 
by the use of a rabbit anti-human CaSr antibody (1:250, Epitomics). Dako secondary anti-rabbit 
antibody and fluorochrome substrate solutions were used according to instructions. To identify 
human ALU-repeat-sequences, chromogenic in situ hybridization (CISH, Zytovision kit) was 
performed according to manufacturer’s instructions. Immunolocalization of BMP-2 was made 
by the use of a polyclonal rabbit anti-human BMP-2 antibody (Santa Cruz Biotechnology) 
followed by DyLight 549 goat anti-rabbit antibody (Jackson Immunoresearch). Pre-immune 
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serum controls were run in parallel. All images were acquired using a phase-contrast Axiovert 
200M microscope (Zeiss).  
 
Ectopic bone formation by hBMSCs 
Ectopic bone formation assay was made according to Muraglia et al. using 2x106 of hBMSCs 
for each scaffold (Muraglia et al., 1998a). Groups of 8 animals were sacrificed at 7 days, 1 and 
2 months. All animals were maintained as required by the Italian Ministry of Health in 
accordance with the standards of the Federation of European Laboratory Animal Science 
Associations (FELASA) (Animal Research Project N°336). 
 
Statistical analysis 
In vitro statistical analysis was performed using 1 way ANOVA (and Nonparametric) for 
Figure 1B; and two-tailed t-test for Figure 1d, 2, 3 and 4.  Error bars indicate standard deviation 
(S.D.). In vivo statistical evaluation was done by using the data from explants of n=8 animals 
for each experimental condition. The data were analysed by two-tailed t-test. Error bars indicate 
standard deviation. For all in vitro and in vivo figures, a p-value 0.05 was considered to be 




MBCPs characterisation  
XRD (single crystal X-ray diffraction) showed the high crystalline content of the granules with 
a ratio of 20% HA and 80% β-TCP for MBCP+® and 60/40 ratio for MBCP+. The total porosity 
in both ceramics was of 70% with a distribution of 25% of micropores (less than 10 µm), 75% 
of mesopores and macropores (over 10 µm, mean size of macropores being 300-600 µm). 
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(Supplementary Figure 1A and B). The granules showed irregular shape with macro 
concavities. Supplementary table 1 shows the results of MicroCT and Hg porosity which does 
not reveal significant differences in the total porosity (75%). However, even without 
significative differences in the overall porosity values, zeta potential of MBCP® are almost three 
times more negative (-31.2 ± 0.4) than those observed in MBCP+® (-13.6 ± 0.9), that could 
interfere with protein CaPs interactions. 
 
In vitro calcium ions release profile  
Calcium release was significantly higher in MBCP+® compared to MBCP® (Supplementary 
Figure 1C). Our data are in agreement with results from other types of ceramic scaffolds, in 
which the presence of a high percentage of tricalcium phosphate compared to hydroxyapatite 
resulted in a faster release of calcium ions (Yuan et al., 2010).  
 
 In vitro co-culture systems 
In vitro assays allow the study of complex biological processes by conducting experiments in 
a highly controlled system with the possibility to investigate cell-cell interactions and to isolate 
secreted growth factors and cytokines released by cells and that are technically hard to be 
identified in vivo. To assess if and how hBMSC seeded onto the two CaP scaffolds could 
differently regulate endothelial cell behaviour, we studied HUVEC proliferation, functionality 
and VEGF content in the described experimental settings: 
hBMSCs – ceramics interaction affects endothelial cell proliferation by modulation of VEGF 
secretion 
We evaluated HUVEC proliferation in the co-culture system described in Figure 1A. 
Significant increase in the number of HUVEC was observed in the cultures performed in the 
presence of BMSC seeded onto either MBCP® or MBCP+® in comparison to HUVEC cultured 
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in the absence of scaffold or in the presence of scaffolds without cells (Figure 1B).  Moreover, 
higher cell number was observed in the presence of BMSC seeded MBCP+® with the number 
of HUVEC in presence of the BMSC seeded into MBCP®. No differences were observed when 
HUVEC cultured in SF medium or in the presence of no acellular scaffolds (Figure 1B). We 
observed an increased number of DAPI positive nuclei in the HUVEC culture in the presence 
of both BMSC seeded scaffolds. Figure 1C represents one group of pictures representative of 
three independent experiments. From the equivalent cultures, conditioned media were collected 
to verify the presence of specific cytokines and growth factors possibly involved in HUVEC 
proliferation/functionality. The enzymatic-linked immunosorbent assay (ELISA) for VEGF 
detection revealed the presence of this growth factor in the conditioned media obtained by 
BMSC seeded onto both ceramic CaP scaffolds. Higher level of secreted VEGF was observed 
in samples from BMSC seeded on MBCP+® in comparison to those to MBCP® (Figure 1D). 
Quantification of VEGF secreted by BMSC cultured in 2D were significantly lower than those 
obtained in 3D cultures of BMSC seeded onto ceramic scaffolds (data not shown).  
 
HUVEC capillary formation as result of the cross-talk with BMSC seeded on ceramics 
The ceramic scaffolds not seeded (controls) and seeded with BMSC were positioned at the 
bottom of multiwell plate and enclosed within matrigel. HUVEC were then placed on the 
matrigel upper surface. Illustration of the experiments is represented in figure 2A. Tube 
formation is typically quantified by measuring number, length and/or area of formed capillary-
like structures observed in two-dimensional microscope. Compared to BMSC cultured onto 
MBCP®, BMSC within MBCP+® conferred to HUVEC a higher sprouting and lumen formation 
capacity already after 6 hours (Figure 2B). After 24 hours, HUVEC in presence of BMSC 
seeded MBCP+® ceramics presented a significantly higher number of tubes formed in 
comparison to those cultured in presence of BMSC seeded MBCP®. The differences in 
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promoting angiogenesis in vitro – i.e. formation of morphologically mature capillaries - can be 
observed in figure 2C.  Neither acellular MBCP® nor MBCP+® were able to sustain capillary 
formation and long-term stability of the vascular networks. 
 
Host vessel sprouting and homing into CaP scaffolds 
Detection and quantification of blood vessels sprouted inside the explanted ceramic scaffolds 
were made using Mallory Trichrome staining (Figure 3). At early implantation time  - figure 
3A - (15 days; first row of inserts), a burst in the presence of blood vessel was observed in both 
scaffolds (stained in gold yellow), being MBCP+® penetrated by a higher number of bigger host 
sprouted vessels in comparison to MBCP®. Similar tendency was observed in 1 month 
explanted scaffolds (middle line inserts).  MBCP+® show a considerably higher number of total 
blood vessels compared to MBCP® scaffold in the overall time. The scaffolds explanted after 
2 months (last inserts) showed an analogous tendency although the total number of blood vessel 
per area has significantly decreased in both scaffolds. After the quantification of the total 
number of blood vessels inside both scaffolds (Figure 3B), we demonstrate that for all time 
points MBCP+® explants (grey columns) presented higher amount of blood vessels in 
comparison to MBCP® samples (black columns). MBCP® explants showed a continual 
reduction of blood vessels from 15 days until 2 months. The amount of blood vessels within 
MBCP+® scaffolds increased from 7 days to the 1 month (not in a statistically significant way). 
Afterwards, we observed a much lower number of blood vessels at 2 months.  
 
Localization of human cells on ceramics explants: activation of calcium sensing receptor on 
hBMSC during bone deposition process 
In situ hybridization was made to confirm the presence of the seeded BMSC in the constructs 
after 1 week implantation and to distinguish between host cells and cells derived from the 
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human seeded BMSC (Figure 4A). Tissue areas were divided in two distinct zones: (i) the 
internal area in direct contact with the scaffolds where cells undoubtedly show a strong 
positivity for human-specific Alu sequence; (ii) zones more external to the ceramics scaffolds, 
but adjacent to the bone deposited by the human cells, that are colonized by host murine cells 
(negative for the presence of human-specific Alu sequence). 
Calcium released by ceramic scaffolds dissolution plays a crucial role in cell osteogenic 
commitment in vivo through Wnt/Ca2+ signalling pathway (Chen et al., 2014). Therefore, we 
searched for the presence of active CaSr in the implanted BMSC seeded onto the two different 
CaP scaffolds (Figure 4B). After 1 week, a higher number of BMSC positive for active CaSr 
were observed in MBCP+® compared to MBCP® (Figure 4B). Positive cells were immediately 
adjacent to the ceramic scaffold.  
 
In vivo neo-bone formation and maturation by BMSC seeded on the two ceramics 
We tested hBMSC capacity to form bone within the two different ceramics in a well established 
ectopic bone formation model consisting in the subcutaneous implantation of cell-ceramic 
constructs in immuno-compromised mice (Muraglia et al., 1998a). BMSC seeded on both CaP 
ceramics gave rise to tissue-engineered ossicles with mineralized bone detectable after 1 and 2 
months (Figure 5A). More specifically, in the MBCP® CaP scaffold, we observed a gradual 
bone deposition with the presence of few osteocytes established within ceramics in the 2 
months explants. The newly formed bone was surrounded by connective tissue where few 
blood vessels were present.  Host cells also colonized the control no cell-seeded scaffolds. 
However, at one month the explants showed the presence of a loose connective tissue in 
between granules. At 2 months the connective tissue was denser with parallel oriented fibres 
especially in areas adjacent to the scaffold, and no bone formation was observed (data not 
shown). Whereas well-organized structures commonly associated to mature bone, such as 
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osteons, were detectable in controls implanted scaffolds seeded with sheep BMSC (data not 
shown). Histomorphometric quantification of new-formed bone indicates an increase of bone 
formation with increased implantation time in both scaffolds, but also statistically significant 
differences between the two ceramics at both 1 and 2 month implantation (Figure 5B). Samples 
explants at 2 months were also prepared for histology according to a resin embedding 
technique, which allows the observation of bone deposition dynamics in non-decalcified 
samples (Canciani et al., 2015). It was possible to observe time dependent differences in the 
bone formation process within the two scaffolds (Figure 5 C). The 1 month MCBP® explants 
showed a rearrangement of the BMSC adjacent to the scaffold surface and the presence of an 
immature bone matrix (I.B.). At the same time, in the MCBP+® scaffolds a tracked line of 
mature bone (M.B.) with embedded osteocytes in contact with the scaffold surface was already 
clearly detectable. Above the mature bone, was present a thin row of unmineralized matrix – 
Osteoid (Os), product of osteoblast (Ob) activity localized on top of it. With increased 
implantation time, the mature bone areas became bigger and denser. In MBCP+®, new-formed 
ossicles were surrounded by well-organized blood vessels (V). 
 
In vivo BMP2 time dependent activation signalling  
To investigate possible mechanisms of the enhanced in vivo osteogenesis in CaP scaffolds 
seeded with BMSC, we looked for the presence of BMP2 taking advantage of antibodies 
directed against the active human protein (Figure 6). Both after 1 and 2 months implantation, 
within MBCP+® scaffolds, but not within the MBCP®, the cells lining the ceramic scaffold 
showed an upregulation of BMP2 protein expression (Figure 6A and B, first line of inserts 
represents MBCP® and the second MBCP+® for the different explants).  This prompted us to 
hypothesize that an initial CaSr activation in the MBCP+® scaffolds triggered a fast bone 
differentiation with activation of BMP2 pathway. 
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Discussion 
Ectopic bone formation by implantation of hBMSCs seeded on different scaffolds is sustained 
by events such as osteoconduction and osteoinduction. Over time, the interaction between 
degradable ceramic scaffolds, hBMSCs and host heterogeneous milieu at the implant site has 
gained the attention of regenerative medicine and tissue engineering scientists. Initial 
angiogenesis is one of the key points to sustain the osteogenic differentiation of the implanted 
cells (S Ghanaati et al., 2011; Kanczler & Oreffo, 2008; Santos et al., 2008). In this study, we 
first addressed our attention to the capacity of hBSMCs on the ceramic scaffolds to sustain in 
vitro HUVEC neo-angiogenic properties. hBMSCs seeded into MBCP+® scaffold induced a 
significant increase in HUVEC mitogenesis compared to the MBCP® scaffolds (p<0.001). For 
both scaffolds, the absence of hBMSCs resulted in a significant (p<0.001) decrease in HUVEC 
number that can indicate that calcium by itself could not play a major role in endothelial cell 
growth. Given these findings, we cannot exclude the possibility that HUVEC calcium sensing 
receptors proteins (CaSr) might be activated by calcium ions released from ceramics but, even 
if this occurred, it was not sufficient to sustain in vitro HUVEC proliferation. In the co-culture 
system, quantified VEGF levels were statistically significantly higher in the presence of 
MBCP+® in comparison to MBCP®. It is known that VEGF has a key role in preserving 
endothelial cell phenotype and viability that sustain vascular integrity (Liu et al., 2004; Masood 
et al., 2001; Mayer et al., 2005; Rosen, 2009; Simorre-Pinatel et al., 1994). hBMSCs seeded in 
CaPs primed the formation of lumen structures by HUVEC demonstrated by the quantification 
of capillary tubes. Capillary tube formation has been proved to be a well-recognized in vitro 
model to study neo-angiogenesis mechanisms (Grant et al., 1995; Herrmann et al., 2014; T 
Mirabella, Cilli, Carlone, Cancedda, & Gentili, 2011). These mechanisms are fundamental in 
bone formation process and a crucial requisite for bone sustainment (Kanczler & Oreffo, 2008; 
Kirkpatrick, Fuchs, & Unger, 2011). By this, several approaches have been proposed to raise 
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scaffold vascularization (Asahara et al., 1997; Jabbarzadeh et al., 2008; Kirkpatrick et al., 2011; 
Rouwkema, de Boer, & Van Blitterswijk, 2006; Verseijden et al., 2010). High level of 
vascularization during bone formation is crucial as the rate and extent of vascularization 
directly relates to bone growth. We showed that already after 15 days of implantation MBCP+® 
seeded with hBMSCs displayed higher presence of blood vessels compared to MBCP®. This 
was maintained over time with a final superior organization of vascular structures (Fig. 3A). 
Calcium ions can be involved in osteogenesis commitment and heterotopic bone formation. It 
has been shown that bioactive ceramics, at the site of implantation could create new apatite 
structures, which promotes cell spreading and osteogenic differentiation (Guy Daculsi, 2015). 
Moreover, the macropores convexity appears to act like a niche for the promotion of bone 
ingrowth and angiogenesis (Antoniac, 2014; Guy Daculsi & Layrolle, 2004). In CaPs the 
physical properties such as porosity and pore interconnectivity are crucial in vascularization, 
e.g., pore sizes directs new vessel formation and different pore sizes are reported to induce 
vessel formation with different diameters (Malhotra & Habibovic, 2016). In situ-hybridization 
demonstrated that cells attached to ceramic granules, mostly in the inner part of the scaffold 
and responsible for the initial neo-formation, are of human origin; while cells lining parallel to 
the granules in the external region are of mouse origin (Fig. 4A). The observation of human 
cells in close contact with ceramics strongly suggests a guidance of the ceramic nature and 
microenvironment on the behaviour of hBMSCs toward osteogenesis. Barradas et al. 
demonstrated that in vitro addition of calcium ions to hBMSCs increased their expression of 
bone related genes, thus indicating that calcium can act as an osteoinductive factor. Our in vivo 
results mirror these in vitro evidences. Presence of human cells in CaP adjacent regions and 
activation of calcium receptor in those cells, early process during calcification of the neo-
formed tissue, was observed mainly in the 1 week explants. hBMSCs in CaP ceramic with high 
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in vitro calcium release presented higher levels of activation of calcium sensing receptor 
(Figure 4B).  
The bone formation efficacy of hBMSCs on both ceramic scaffolds was evaluated and 
quantified up to 2 months (Figure 5A and B). In MBCP+® scaffolds at 1 month, hBMSCs 
generated bone tissue with parallel orientation to the ceramic surface with osteocytes (Oc) full 
embedded in their dense collagen matrix deposited by the aligned osteoblasts (Ob).  
During development, vascularization precedes osteogenesis in both endochondral and 
intramembranous ossification processes (Kronenberg et al., 2003; Trueta et al.,1960; Zelzer et 
al., 2004). At late time, the presence of organized vascular structures with bone marrow inside 
the formed bone reinforces the significant role of calcium-released ions from the ceramic at 
both morphological-structure scale and molecular level. In agreement with previous data 
published by our laboratory (M Mastrogiacomo et al., 2007; Papadimitropoulos et al., 2007), 
both implanted acellular ceramics, per se, did not display any trace of deposited bone tissue 
during the observation period. These outcomes mirror some results obtained in osteoinductive 
studies in small animals where it was demonstrated that CaP ceramics induced bone formation 
only in two of eleven different inbred mouse strains (Ana M C Barradas, Yuan, et al., 2012).  
Several authors demonstrated, with very elegant in vitro experiments a direct relationship 
between calcium cellular sensing level and BMP-2 expression during bone formation by 
hBMSCs. The in vitro acting mechanism is activated and up-regulated by an unknown calcium 
sensing protein similar to calcium sensing receptor (Aldebaran M Hofer, 2005; Kanaya, 
Nemoto, Sakisaka, & Shimauchi, 2013; Tada et al., 2010). Other indication of a faster and 
sustained osteogenic commitment conducted by CaP ceramics on cells was the observation of 
active hBMP2. This member of BMP family acts as an osteoinductive agent by activation of 
its receptor that thought SMAD-dependent and independent pathways leads to osteoblast 
differentiation of mesenchymal progenitor cells (Bais et al., 2009; Soltanoff, Yang, Chen, & 
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Li, 2009).  Indeed, we observed a difference in the number of hBMP2 positive cells in the two 
explanted ceramics. Calcium released during CaP scaffold degradation can play a fundamental 
role in osteogenic commitment of seeded and nearby cells through Wnt/Ca2+ signalling 
pathway leading to BMP2 expression. It was reported that the activation of CaSr induces BMP2 
synthesis and secretion via phosphatidylinoditol-3-kinase. Exclusion of CaSr totally inhibited 
BMP2 activation (Peiris, Pacheco, Spencer, & MacLeod, 2007). Moreover, we observed a 
higher number of positive human BMP2 cells on MBCP+® compared to those in MBCP®, 
which re-enforces the idea that the in vivo up-regulation of BMP2 can be related with the up-
regulation of CaSr. 
 
Conclusions 
We have shown that high content of β–TCP on ceramic scaffolds affects hBMSCs seeded cells 
ability both to sustain angiogenesis and to promote mature osteogenesis differentiation by an 
endochondral bone process. 
Firstly, the release of calcium ions from CaP ceramics was related to a high secretion of VEGF 
in seeded hBMSCs, which acts in paracrine mode on endothelial cells priming mitogenesis and 
capillary tube formation. We showed that ectopically implanted scaffolds with a higher amount 
of β–TCP elicited superior and faster host vascular spreading and sustenance than the scaffold 
with a lower β–TCP content. The prompted hBMSCs osteogenesis could be triggered by 
calcium ions released from CaP scaffold in an ectopic mouse microenvironment. In this niche, 
Ca2+ ions drove a faster bone formation with an observed activation of hBMSCs calcium 
receptor. Bone formed by hBMSCs resulted to be more robust over time with upregulation of 
BMP2. 
Our work highlights the importance of the ceramic scaffold composition in bone formation and 
maintenance by hBMSCs. These findings could guide future ceramics developments. 
 
 
This article is protected by copyright. All rights reserved. 
Acknowledgements 
The authors gratefully acknowledge the financial support of the “GAMBA” EU-Project from 




Antoniac, I. V. (Ed.). (2014). Handbook of Bioceramics and Biocomposites. Cham: Springer 
International Publishing. https://doi.org/10.1007/978-3-319-09230-0 
Asahara, T., Murohara, T., Sullivan, A., Silver, M., van der Zee, R., Li, T., … Isner, J. M. 
(1997). Isolation of putative progenitor endothelial cells for angiogenesis. Science (New 
York, N.Y.), 275(5302), 964–967. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9020076 
Bais, M. V, Wigner, N., Young, M., Toholka, R., Graves, D. T., Morgan, E. F., … Einhorn, 
T. A. (2009). BMP2 is essential for post natal osteogenesis but not for recruitment of 
osteogenic stem cells. Bone, 45(2), 254–266. https://doi.org/10.1016/j.bone.2009.04.239 
Barradas, A. M. C., Fernandes, H. A. M., Groen, N., Chai, Y. C., Schrooten, J., van de 
Peppel, J., … de Boer, J. (2012). A calcium-induced signaling cascade leading to 
osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. 
Biomaterials, 33(11), 3205–3215. https://doi.org/10.1016/j.biomaterials.2012.01.020 
Barradas, A. M. C., Monticone, V., Hulsman, M., Danoux, C., Fernandes, H., Tahmasebi 
Birgani, Z., … de Boer, J. (2013). Molecular mechanisms of biomaterial-driven 
osteogenic differentiation in human mesenchymal stromal cells. Integrative Biology : 
Quantitative Biosciences from Nano to Macro, 5(7), 920–931. 
https://doi.org/10.1039/c3ib40027a 
Barradas, A. M. C., Yuan, H. P., van Blitterswijk, C. A., & Habibovic, P. (2011). 
Osteoinductive Biomaterials: Current Knowledge of Properties, Experimental Models 
and Biological Mechanisms. European Cells & Materials, 21, 407–429. 
Barradas, A. M. C., Yuan, H. P., van der Stok, J., Le Quang, B., Fernandes, H., Chaterjea, A., 
… de Boer, J. (2012). The influence of genetic factors on the osteoinductive potential of 
calcium phosphate ceramics in mice. Biomaterials, 33(23), 5696–5705. 
https://doi.org/Doi 10.1016/J.Biomaterials.2012.04.021 
Barradas, A. M. C., Yuan, H. P., van der Stok, J., Quang, B. L., Fernandes, H., Chaterje, A., 
… de Boer, J. (2012). The influence of genetic factors on the osteoinductive potential of 
calcium phosphate ceramics in mice. Biomaterials, 33(23), 5696–5705. 
https://doi.org/Doi 10.1016/J.Biomaterials.2012.04.021 
Bianco, P., Cancedda, F. D., Riminucci, M., & Cancedda, R. (1998). Bone formation via 
cartilage models: the “borderline” chondrocyte. Matrix Biology : Journal of the 
International Society for Matrix Biology, 17(3), 185–192. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/9707341 
Cancedda, R., Bianchi, G., Derubeis, A., & Quarto, R. (2003). Cell therapy for bone disease: 
 
 
This article is protected by copyright. All rights reserved. 
A review of current status. Stem Cells, 21(5), 610–619. https://doi.org/Doi 
10.1634/Stemcells.21-5-610 
Canciani, B., Ruggiu, A., Giuliani, A., Panetta, D., Marozzi, K., Tripodi, M., … Tavella, S. 
(2015). Effects of long time exposure to simulated micro- and hypergravity on skeletal 
architecture. Journal of the Mechanical Behavior of Biomedical Materials, 51, 1–12. 
https://doi.org/10.1016/j.jmbbm.2015.06.014 
Chen, Z. T., Wu, C. T., Gu, W. Y., Klein, T., Crawford, R., & Xiao, Y. (2014). Osteogenic 
differentiation of bone marrow MSCs by beta-tricalcium phosphate stimulating 
macrophages via BMP2 signalling pathway. Biomaterials, 35(5), 1507–1518. 
https://doi.org/Doi 10.1016/J.Biomaterials.2013.11.014 
Daculsi, G. (2015). Smart scaffolds: the future of bioceramic. Journal of Materials Science. 
Materials in Medicine, 26(4), 154. https://doi.org/10.1007/s10856-015-5482-7 
Daculsi, G., Fellah, B. H., Miramond, T., & Durand, M. (2013). Osteoconduction, 
Osteogenicity, Osteoinduction, what are the fundamental properties for a smart bone 
substitutes. IRBM, 34(4–5), 346–348. https://doi.org/10.1016/j.irbm.2013.07.001 
Daculsi, G., Laboux, O., Malard, O., & Weiss, P. (2003). Current state of the art of biphasic 
calcium phosphate bioceramics. Journal of Materials Science-Materials in Medicine, 
14(3), 195–200. https://doi.org/Doi 10.1023/A:1022842404495 
Daculsi, G., & Layrolle, P. (2004). Osteoinductive Properties of Micro Macroporous 
Biphasic Calcium Phosphate Bioceramics. Key Engineering Materials, 254–256, 1005–
1008. https://doi.org/10.4028/www.scientific.net/KEM.254-256.1005 
Daculsi, G., Miramond, T., Borget, P., & Baroth, S. (2012). Smart Calcium Phosphate 
Bioceramic Scaffold for Bone Tissue Engineering. Key Engineering Materials, 529–
530, 19–23. https://doi.org/10.4028/www.scientific.net/KEM.529-530.19 
El Backly, R. M., Zaky, S. H., Muraglia, A., Tonachini, L., Brun, F., Canciani, B., … 
Mastrogiacomo, M. (2013). A platelet-rich plasma-based membrane as a periosteal 
substitute with enhanced osteogenic and angiogenic properties: a new concept for bone 
repair. Tissue Engineering. Part A, 19(1–2), 152–165. 
https://doi.org/10.1089/ten.TEA.2012.0357 
Espitalier, F., Vinatier, C., Lerouxel, E., Guicheux, J., Pilet, P., Moreau, F., … Malard, O. 
(2009). A comparison between bone reconstruction following the use of mesenchymal 
stem cells and total bone marrow in association with calcium phosphate scaffold in 
irradiated bone. Biomaterials, 30(5), 763–769. https://doi.org/Doi 
10.1016/J.Biomaterials.2008.10.051 
Ferrara, N., Gerber, H. P., & LeCouter, J. (2003). The biology of VEGF and its receptors. 
Nature Medicine, 9(6), 669–676. https://doi.org/Doi 10.1038/Nm0603-669 
Ghanaati, S., Barbeck, M., Orth, C., Willershausen, I., Thimm, B. W., Hoffmann, C., … 
Kirkpatrick, C. J. (2010). Influence of β-tricalcium phosphate granule size and 
morphology on tissue reaction in vivo. Acta Biomaterialia, 6(12), 4476–4487. 
https://doi.org/10.1016/j.actbio.2010.07.006 
Ghanaati, S., Unger, R. E., Webber, M. J., Barbeck, M., Orth, C., Kirkpatrick, J. A., … 
Kirkpatrick, C. J. (2011). Scaffold vascularization in vivo driven by primary human 
osteoblasts in concert with host inflammatory cells. Biomaterials, 32(32), 8150–8160. 
https://doi.org/Doi 10.1016/J.Biomaterials.2011.07.041 
Goshima, J., Goldberg, V. M., & Caplan, A. I. (1991). The osteogenic potential of culture-
 
 
This article is protected by copyright. All rights reserved. 
expanded rat marrow mesenchymal cells assayed in vivo in calcium phosphate ceramic 
blocks. Clinical Orthopaedics and Related Research, (262), 298–311. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/1984928 
Grant, D. S., Kinsella, J. L., Kibbey, M. C., LaFlamme, S., Burbelo, P. D., Goldstein, A. L., 
& Kleinman, H. K. (1995). Matrigel induces thymosin beta 4 gene in differentiating 
endothelial cells. Journal of Cell Science, 108 ( Pt 1, 3685–3694. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/8719875 
Herrmann, M., Binder, A., Menzel, U., Zeiter, S., Alini, M., & Verrier, S. (2014). 
CD34/CD133 enriched bone marrow progenitor cells promote neovascularization of 
tissue engineered constructs in vivo. Stem Cell Research, 13(3 Pt A), 465–477. 
https://doi.org/10.1016/j.scr.2014.10.005 
Hofer, A. M. (2005). Another dimension to calcium signaling: a look at extracellular calcium. 
Journal of Cell Science, 118(Pt 5), 855–862. https://doi.org/10.1242/jcs.01705 
Hofer, A. M., & Lefkimmiatis, K. (2007). Extracellular calcium and cAMP: Second 
messengers as “third messengers”? Physiology, 22(5), 320–327. https://doi.org/Doi 
10.1152/Physiol.00019.2007 
Jabbarzadeh, E., Starnes, T., Khan, Y. M., Jiang, T., Wirtel, A. J., Deng, M., … Laurencin, C. 
T. (2008). Induction of angiogenesis in tissue-engineered scaffolds designed for bone 
repair: a combined gene therapy-cell transplantation approach. Proceedings of the 
National Academy of Sciences of the United States of America, 105(32), 11099–11104. 
https://doi.org/10.1073/pnas.0800069105 
Kanaya, S., Nemoto, E., Sakisaka, Y., & Shimauchi, H. (2013). Calcium-mediated increased 
expression of fibroblast growth factor-2 acts through NF-κB and PGE2/EP4 receptor 
signaling pathways in cementoblasts. Bone, 56(2), 398–405. 
https://doi.org/10.1016/j.bone.2013.06.031 
Kanczler, J. M., & Oreffo, R. O. C. (2008). Osteogenesis and angiogenesis: The potential for 
engineering bone. European Cells & Materials, 15, 100–114. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/18454418 
Khlusov, I. A., Karlov, A. V, Sharkeev, Y. P., Pichugin, V. F., Kolobov, Y. P., Shashkina, G. 
A., … Sukhikh, G. T. (2005). Osteogenic potential of mesenchymal stem cells from 
bone marrow in situ: role of physicochemical properties of artificial surfaces. Bulletin of 
Experimental Biology and Medicine, 140(1), 144–152. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/16254641 
Kirkpatrick, C. J., Fuchs, S., & Unger, R. E. (2011). Co-culture systems for vascularization--
learning from nature. Advanced Drug Delivery Reviews, 63(4–5), 291–299. 
Komlev, V. S., Mastrogiacomo, M., Pereira, R. C., Peyrin, F., Rustichelli, F., & Cancedda, R. 
(2010). Biodegradation of Porous Calcium Phosphate Scaffolds in an Ectopic Bone 
Formation Model Studied by X-Ray Computed Microtomography. European Cells & 
Materials, 19, 136–146. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20349404 
Kronenberg, H. M. (2003). Developmental regulation of the growth plate. Nature, 423(6937), 
332–336. https://doi.org/10.1038/nature01657 
Le Nihouannen, D., Daculsi, G., Saffarzadeh, A., Gauthier, O., Delplace, S., Pilet, P., & 
Layrolle, P. (2005). Ectopic bone formation by microporous calcium phosphate ceramic 




This article is protected by copyright. All rights reserved. 
LeGeros, R. Z. (2008). Calcium Phosphate-Based Osteoinductive Materials. Chemical 
Reviews, 108(11), 4742–4753. https://doi.org/Doi 10.1021/Cr800427g 
Liu, Y., De Groot, K., & Hunziker, E. B. (2004). Osteoinductive implants: The Mise-en-
scene for drug-bearing biomimetic coatings. Annals of Biomedical Engineering, 32(3), 
398–406. https://doi.org/Doi 10.1023/B:Abme.0000017536.10767.0f 
Malhotra, A., & Habibovic, P. (2016). Calcium Phosphates and Angiogenesis: Implications 
and Advances for Bone Regeneration. Trends in Biotechnology, 34(12), 983–992. 
https://doi.org/10.1016/j.tibtech.2016.07.005 
Masood, R., Cai, J., Zheng, T., Smith, D. L., Hinton, D. R., & Gill, P. S. (2001). Vascular 
endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-
positive human tumors. Blood, 98(6), 1904–1913. Retrieved from 
http://www.ncbi.nlm.nih.gov/pubmed/11535528 
Mastrogiacomo, M., Papadimitropoulos, A., Cedola, A., Peyrin, F., Giannoni, P., Pearce, S. 
G., … Cancedda, R. (2007). Engineering of bone using bone marrow stromal cells and a 
silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between 
bone formation and scaffold resorption. Biomaterials, 28(7), 1376–1384. 
https://doi.org/10.1016/j.biomaterials.2006.10.001 
Mastrogiacomo, M., Scaglione, S., Martinetti, R., Dolcini, L., Beltrame, F., Cancedda, R., & 
Quarto, R. (2006). Role of scaffold internal structure on in vivo bone formation in 
macroporous calcium phosphate bioceramics. Biomaterials, 27(17), 3230–3237. 
https://doi.org/10.1016/j.biomaterials.2006.01.031 
Matsubara, T., Kida, K., Yamaguchi, A., Hata, K., Ichida, F., Meguro, H., … Yoneda, T. 
(2008). BMP2 Regulates Osterix through Msx2 and Runx2 during Osteoblast 
Differentiation. Journal of Biological Chemistry, 283(43), 29119–29125. 
https://doi.org/Doi 10.1074/Jbc.M801774200 
Mayer, H., Bertram, H., Lindenmaier, W., Korff, T., Weber, H., & Weich, H. (2005). 
Vascular endothelial growth factor (VEGF-A) expression in human mesenchymal stem 
cells: autocrine and paracrine role on osteoblastic and endothelial differentiation. 
Journal of Cellular Biochemistry, 95(4), 827–839. https://doi.org/10.1002/jcb.20462 
Mirabella, T., Cilli, M., Carlone, S., Cancedda, R., & Gentili, C. (2011). Amniotic liquid 
derived stem cells as reservoir of secreted angiogenic factors capable of stimulating neo-
arteriogenesis in an ischemic model. Biomaterials, 32(15), 3689–3699. 
https://doi.org/10.1016/j.biomaterials.2011.01.071 
Mirabella, T., Poggi, A., Scaranari, M., Mogni, M., Lituania, M., Baldo, C., … Gentili, C. 
(2011). Recruitment of host’s progenitor cells to sites of human amniotic fluid stem cells 
implantation. Biomaterials, 32(18), 4218–4227. 
https://doi.org/10.1016/j.biomaterials.2010.12.028 
Muraglia, A., Martin, I., Cancedda, R., & Quarto, R. (1998a). A nude mouse model for 
human bone formation in unloaded conditions. Bone, 22(5 Suppl), 131S–134S. 
Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9600769 
Muraglia, A., Martin, I., Cancedda, R., & Quarto, R. (1998b). A Nude Mouse Model for 
Human Bone Formation in Unloaded Conditions. Bone, 22(5), 131S–134S. 
https://doi.org/10.1016/S8756-3282(98)00009-X 
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011). Vascularization is the key challenge in 




This article is protected by copyright. All rights reserved. 
Oreffo, R. O. C., & Triffitt, J. T. (1999). Future potentials for using osteogenic stem cells and 
biomaterials in orthopedics. Bone, 25(2), 5s–9s. https://doi.org/Doi 10.1016/S8756-
3282(99)00124-6 
Papadimitropoulos, A., Mastrogiacomo, M., Peyrin, F., Molinari, E., Komlev, V. S., 
Rustichelli, F., & Cancedda, R. (2007). Kinetics of in vivo bone deposition by bone 
marrow stromal cells within a resorbable porous calcium phosphate scaffold: an X-ray 
computed microtomography study. Biotechnology and Bioengineering, 98(1), 271–281. 
https://doi.org/10.1002/bit.21418 
Peiris, D., Pacheco, I., Spencer, C., & MacLeod, R. J. (2007). The extracellular calcium-
sensing receptor reciprocally regulates the secretion of BMP-2 and the BMP antagonist 
Noggin in colonic myofibroblasts. American Journal of Physiology. Gastrointestinal 
and Liver Physiology, 292(3), G753-66. https://doi.org/10.1152/ajpgi.00225.2006 
Place, E. S., Evans, N. D., & Stevens, M. M. (2009). Complexity in biomaterials for tissue 
engineering. Nature Materials, 8(6), 457–470. https://doi.org/Doi 10.1038/Nmat2441 
Quarto, R., Mastrogiacomo, M., Cancedda, R., Kutepov, S. M., Mukhachev, V., Lavroukov, 
A., … Marcacci, M. (2001). Repair of large bone defects with the use of autologous 
bone marrow stromal cells. New England Journal of Medicine, 344(5), 385–386. 
https://doi.org/Doi 10.1056/Nejm200102013440516 
Rosen, V. (2009). BMP2 signaling in bone development and repair. Cytokine & Growth 
Factor Reviews, 20(5–6), 475–480. https://doi.org/Doi 10.1016/J.Cytogfr.2009.10.018 
Rouwkema, J., de Boer, J., & Van Blitterswijk, C. A. (2006). Endothelial cells assemble into 
a 3-dimensional prevascular network in a bone tissue engineering construct. Tissue 
Engineering, 12(9), 2685–2693. https://doi.org/10.1089/ten.2006.12.2685 
Rubio, R., Abarrategi, A., Garcia-Castro, J., Martinez-Cruzado, L., Suarez, C., Tornin, J., … 
Rodriguez, R. (2014). Bone environment is essential for osteosarcoma development 
from transformed mesenchymal stem cells. Stem Cells (Dayton, Ohio), 32(5), 1136–
1148. https://doi.org/10.1002/stem.1647 
Santos, M. I., Tuzlakoglu, K., Fuchs, S., Gomes, M. E., Peters, K., Unger, R. E., … 
Kirkpatrick, C. J. (2008). Endothelial cell colonization and angiogenic potential of 
combined nano- and micro-fibrous scaffolds for bone tissue engineering. Biomaterials, 
29(32), 4306–4313. https://doi.org/Doi 10.1016/J.Biomaterials.2008.07.033 
Simorre-Pinatel, V., Guerrin, M., Chollet, P., Penary, M., Clamens, S., Malecaze, F., & 
Plouet, J. (1994). Vasculotropin-VEGF stimulates retinal capillary endothelial cells 
through an autocrine pathway. Investigative Ophthalmology & Visual Science, 35(9), 
3393–3400. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8056513 
Soltanoff, C. S., Yang, S., Chen, W., & Li, Y.-P. (2009). Signaling networks that control the 
lineage commitment and differentiation of bone cells. Critical Reviews in Eukaryotic 
Gene Expression, 19(1), 1–46. Retrieved from 
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3392028&tool=pmcentrez&
rendertype=abstract 
Tada, H., Nemoto, E., Kanaya, S., Hamaji, N., Sato, H., & Shimauchi, H. (2010). Elevated 
extracellular calcium increases expression of bone morphogenetic protein-2 gene via a 
calcium channel and ERK pathway in human dental pulp cells. Biochemical and 
Biophysical Research Communications, 394(4), 1093–1097. 
https://doi.org/10.1016/j.bbrc.2010.03.135 
Tampieri, A., Sprio, S., Sandri, M., & Valentini, F. (2011). Mimicking natural bio-
 
 
This article is protected by copyright. All rights reserved. 
mineralization processes: A new tool for osteochondral scaffold development. Trends in 
Biotechnology, 29(10), 526–535. https://doi.org/Doi 10.1016/J.Tibtech.2011.04.011 
TRUETA, J., & LITTLE, K. (1960). The vascular contribution to osteogenesis. II. Studies 
with the electron microscope. The Journal of Bone and Joint Surgery. British Volume, 
42–B, 367–376. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/13855126 
Tsai, T.-L., Wang, B., Squire, M. W., Guo, L.-W., & Li, W.-J. Endothelial cells direct human 
mesenchymal stem cells for osteo- and chondro-lineage differentiation through 
endothelin-1 and AKT signaling. Stem Cell Research & Therapy, 6(1), 88. 
https://doi.org/10.1186/s13287-015-0065-6 
Verseijden, F., Posthumus-van Sluijs, S. J., Pavljasevic, P., Hofer, S. O. P., van Osch, G. J. 
V. M., & Farrell, E. (2010). Adult human bone marrow- and adipose tissue-derived 
stromal cells support the formation of prevascular-like structures from endothelial cells 
in vitro. Tissue Engineering. Part A, 16(1), 101–114. 
https://doi.org/10.1089/ten.TEA.2009.0106 
Yao, H., Miura, Y., Yoshioka, S., Miura, M., Hayashi, Y., Tamura, A., … Maekawa, T. 
(2014). Parathyroid Hormone Enhances Hematopoietic Expansion Via Upregulation of 
Cadherin-11 in Bone Marrow Mesenchymal Stromal Cells. Stem Cells, 32(8), 2245–
2255. https://doi.org/Doi 10.1002/Stem.1701 
Yuan, H., Fernandes, H., Habibovic, P., de Boer, J., Barradas, A. M. C., de Ruiter, A., … de 
Bruijn, J. D. (2010). Osteoinductive ceramics as a synthetic alternative to autologous 
bone grafting. Proceedings of the National Academy of Sciences of the United States of 
America, 107(31), 13614–13619. https://doi.org/10.1073/pnas.1003600107 
Zelzer, E., Mamluk, R., Ferrara, N., Johnson, R. S., Schipani, E., & Olsen, B. R. (2004). 
VEGFA is necessary for chondrocyte survival during bone development. Development 





This article is protected by copyright. All rights reserved. 
 
 
Figure 1 – A - Draft of experimental conditions for HUVEC proliferation assay using a non-
direct co-culture system. - HUVECs cultured in HUVEC medium; - HUVECs cultured in 
Serum free medium (Sf); - HUVECs cultured in Sf medium exposed to MBCP® supernatant; 
- HUVECs cultured in Sf medium exposed to MBCP® seeded with hBMSCs supernatant; - 
HUVECs culture in SF medium exposed to MBCP+® supernatant; -HUVECs cultured in Sf 
medium exposed to MBCP+® seeded with hBMSCs supernatant.  B - Quantification of 
HUVEC nuclei number for each culture conditions. Data acquired from four independent 
experiments. C - Representative images of HUVEC stained nuclei co-cultured under different 
conditions; - HUVEC cultured in standard HUVEC media, - HUVEC cultured in Sf media, - 
HUVEC cultured in presence of MBCP®, - HUVEC cultured with hBMSCs seeded into 
MBCP®, - HUVEC cultured in presence of MBCP+®, - HUVEC cultured with hBMSCs 
seeded into MBCP+®. D -  Vascular endothelial growth factor (VEGF) quantification by 
ELISA, (n=3). *, figure 1B 1 way ANOVA (Nonparametric with post test TUKEY using 
family error rate of 0.05 value is statistically significant; * figure  1D t-test p < 0.001 is 
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Figure 2 – HUVEC in vitro capillary tube formation. A - Draft of experimental conditions 
for HUVEC proliferation assay using a non-direct co-culture system in matrigel. - HUVECs 
cultured in Sf medium exposed to MBCP® supernatant; - HUVECs cultured in Sf medium 
exposed to MBCP® seeded with hBMSCs supernatant; - HUVECs culture in Sf medium 
exposed to MBCP+® supernatant; - HUVECs cultured in Sf medium exposed to MBCP+® 
seeded with hBMSCs supernatant. B - Over time quantification of HUVEC capillary tubes 
formed per region of interest (ROI) on the different conditions. C -  Representative images of 
HUVEC seeded into the top layer of Matrigel co-cultured on the different conditions; Huvec 
in presence of hBSMCs seeded into MBCP® (first row); Huvec in presence of hBMSCs 
seeded into MBCP+® (second row). Microscope pictures were acquired after 6 and 24 hours 
of co-culture. Data from three independent experiments. *, t-test with p < 0.001 is statistically 
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Figure 3 - Detection of vascular structures sprouted into the different ceramic scaffolds 
seeded with hBMSCs. A - Histological sections of explants stained with Mallory’s trichome: 
MBCP® ceramics with hBMSCs after 2 weeks, 1 and 2 months respectively (left); and 
MBCP+® ceramics with hBMSCs after 2 weeks, 1 and 2 months (right). B -  Quantification of 
the number of blood vessels inside both different ceramic scaffolds over time. Error bars 
represent standard deviations. Asterisk (*) indicate statistical difference (t-test) p< 0.05. Scale 
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Figure 4 – Histological analysis of the in vivo engineered tissue in both calcium phosphate 
ceramics after 2 weeks. A - In situ Hybridization for human ALU repeated sequence; - large 
spectrum of all cellular populations within the ceramic; detailed visualization of human 
(internal zone) and mice (external zone) cells present into the calcium phosphate scaffolds. 
Scale bar = 100μm. B - Immune detection of CaSr active protein on implanted hBMSCs; - 
MBCP® ceramic scaffold and - MBCP+® respectively. Black arrows indicate the positive 
human cells on MBCP+® for hCaSr immune peroxidase. H&E was used as counterstaining. 
Scale bar = 100μm.  Sc – Scaffold; Hc – Human Cells; Mc – Mice cells. 
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Figure 5 -  Osteogenic differentiation of hBMSCs on calcium phosphate scaffolds. A - 
Histological sections stained Hematoxylin and Eosin (H&E) of explants; MBCP® with 
hBMSCs after 1 and 2 months respectively (left); MBCP+® ceramics with hBMSCs after 1 
and 2 months respectively (right). B - Quantification of bone area formed within different 
ceramics over time. C - Osteogenic differentiation potential of hBMSCs on both calcium 
phosphate ceramics on non-decalcified explants; Histological sections stained with Van 
Geison MBCP® and MBCP+®, both loaded with bBMSCs implanted for 1 and 2 months 
respectively. Sc – scaffold; Ft – fibrotic tissue; Oc – osteocytes; Ob – osteoblasts; Os – 
osteoide; V – vessels; M.B. – Mature bone; I.B. – Immature bone and BM – bone marrow. 
The error bars represents standard deviations. Asterisk (*) denotes statistical difference in t-
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Figure 6 – Immunofluorescence detection of hBMP2 on calcium phosphate ceramics 
explants. Fluorescence microscopy images of hBMP2 on human BMSCs seeded into MBCP® 
(1-3 row) and MBCP+® (2-4 row) CaP ceramics respectively at 1 month (A) and two months 
(B). DAPI (4',6-diamidino-2-phenylindole) was used as nuclear acid staining. Dashed lines 
label the scaffold (Sc). Scale bar = 100μm. 
 
 
 
